Abstract
BackgroundSince cytomegalovirus (CMV) infection can cause serious clinical complications in immunocompromised individuals, we assessed cellular immune requirements for protection against CMV end-organ disease (CMV-EOD) in human immunodeficiency virus type 1 (HIV-1) infection MethodsLongitudinal samples from HIV-1–infected patients in the Amsterdam cohort were analyzed. Dynamics of CMV-specific CD8+ and CD4+ T
... read more